1. Home
  2. NRSN vs OPTX Comparison

NRSN vs OPTX Comparison

Compare NRSN & OPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • OPTX
  • Stock Information
  • Founded
  • NRSN 2017
  • OPTX 1981
  • Country
  • NRSN Israel
  • OPTX United States
  • Employees
  • NRSN N/A
  • OPTX N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • OPTX Blank Checks
  • Sector
  • NRSN Health Care
  • OPTX Finance
  • Exchange
  • NRSN Nasdaq
  • OPTX Nasdaq
  • Market Cap
  • NRSN 58.8M
  • OPTX 51.9M
  • IPO Year
  • NRSN 2021
  • OPTX N/A
  • Fundamental
  • Price
  • NRSN $1.91
  • OPTX $1.35
  • Analyst Decision
  • NRSN Buy
  • OPTX
  • Analyst Count
  • NRSN 2
  • OPTX 0
  • Target Price
  • NRSN $14.00
  • OPTX N/A
  • AVG Volume (30 Days)
  • NRSN 442.8K
  • OPTX 73.0K
  • Earning Date
  • NRSN 07-11-2025
  • OPTX 08-13-2025
  • Dividend Yield
  • NRSN N/A
  • OPTX N/A
  • EPS Growth
  • NRSN N/A
  • OPTX N/A
  • EPS
  • NRSN N/A
  • OPTX 0.00
  • Revenue
  • NRSN N/A
  • OPTX $29,392,186.00
  • Revenue This Year
  • NRSN N/A
  • OPTX N/A
  • Revenue Next Year
  • NRSN N/A
  • OPTX N/A
  • P/E Ratio
  • NRSN N/A
  • OPTX $846.97
  • Revenue Growth
  • NRSN N/A
  • OPTX 4.00
  • 52 Week Low
  • NRSN $0.51
  • OPTX $0.85
  • 52 Week High
  • NRSN $2.60
  • OPTX $5.10
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 51.18
  • OPTX 42.25
  • Support Level
  • NRSN $2.04
  • OPTX $1.27
  • Resistance Level
  • NRSN $2.35
  • OPTX $1.39
  • Average True Range (ATR)
  • NRSN 0.25
  • OPTX 0.11
  • MACD
  • NRSN -0.04
  • OPTX -0.01
  • Stochastic Oscillator
  • NRSN 28.74
  • OPTX 21.43

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

Share on Social Networks: